AgomAb Therapeutics N.V. American Shares
AGMB | NASDAQ
$7.49
-$0.46 (-5.79%)
At close: Oct 30, 2026, 4:00 PM ET
$7.49
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Market Data
Market Cap $368.87M
Enterprise Value $72.11M
Beta 1.80
Average Volume 131.53K
Shares Outstanding (Diluted) 48.74M
Shares Change YoY N/A
Institutional Ownership 53.26%
Exchange NASDAQ
ISIN US00860C1027
Price Performance
Price Change 1M -32.5%
Price Change 3M -41.8%
Price Change 6M -33.1%
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -38.5%
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR -60.2%
Valuation
PE Ratio -8.36
Forward PE N/A
PEG Ratio -0.08
Forward PEG 0.34
PS Ratio N/A
Forward PS 619.60
PB Ratio 1.22
P/FCF Ratio -12.13
P/Adj. FCF Ratio -11.00
P/OCF Ratio -12.01
EV/Sales N/A
EV/EBIT -2.02
EV/EBITDA -2.02
EV/FCF -2.69
Earnings Yield -11.8%
FCF Yield -8.2%
Adj. FCF Yield -9.0%
Financial Health
Net Cash €251.98M
Total Debt €1.14M
Cash & Short-Term Investments €251.98M
Total Assets €290.92M
Current Ratio 12.88
Quick Ratio 12.88
Debt / Equity Ratio 0.00
Debt / EBITDA -0.03
Debt / FCF -0.04
OCF / Debt -23.54
Interest Coverage -257.11
Altman Z-Score 7.14
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -10.3%
Returns
Return on Assets -12.3%
Return on Equity -19.7%
Return on Invested Capital -11.8%
Return on Capital Employed -11.8%
Return on Tangible Assets -13.6%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -51.0%
EPS CAGR 5Y N/A
EPS CAGR 10Y N/A
FCF CAGR 3Y N/A
FCF CAGR 5Y N/A
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y -66.2%
Revenue Growth Next 3Y N/A
Earnings Date Mar 3, 2027
EPS Estimate (next Q) -$1.06
EPS Growth Est (next Q) 163.3%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $35.00
Price Target Upside 367.3%
Cash Flow
Operating Cash Flow €-26.81M
Free Cash Flow €-26.81M
Adj. Free Cash Flow €-29.57M
FCF Per Share -$0.55
OCF Per Share -$0.55
OCF/S Ratio 0.0%
Income Statement
Revenue €0
Gross Profit €0
Operating Income €-31.88M
EBITDA €-35.67M
Net Income €-35.68M
EPS (Diluted) -$0.79
Revenue / Employee N/A
Profit / Employee $-575.47K
Employees 62
Add to Watchlist
Select watchlists to add or remove AGMB